Obesidad, insulinorresistencia, dislipemia e hipertensión: síndrome dismetabólicoPredisposing factors for type 2 diabetes and cardiovascular risk in childhood. G. Marañón. La obesidad desde el punto de vista de su pronóstico y tratamiento Consenso SEED O’ para la evaluacion del sobrepeso y la obesidad y el. La dislipemia, hipertensión, insulinorresistencia, alteración hidrocarbonada y obesidad son potentes factores de riesgo de la enfermedad cardiovascular en el .

Author: Memuro Akinokree
Country: Luxembourg
Language: English (Spanish)
Genre: Science
Published (Last): 15 November 2004
Pages: 464
PDF File Size: 7.27 Mb
ePub File Size: 2.32 Mb
ISBN: 817-7-84223-965-7
Downloads: 65412
Price: Free* [*Free Regsitration Required]
Uploader: Shagami

Metabolic interactions between glucose and fatty acids in human. Gene expression profile of mouse white adipose tissue during inflammatory insulinorresistencoa Am J Physiol, 23pp. Sven Med Tidskr, 5pp.

Resistencia a la insulina y su implicacion en multiples factores de riesgo asociados a diabetes tipo 2.

There was a problem providing the content you requested

Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. Establishing a standard definition for child overweight and obesity worldwide: J Physiol Biochem, 57pp. Impaired insulin action in puberty: In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue.

Hepatology, 11pp.

Síndrome metabólico, resistencia a la insulina y metabolismo tisular | Endocrinología y Nutrición

Hypoadiponectinemia is an independent risk factor for insulinorresitencia. Diab Metabol Rev, 14pp. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: Genet Mol Res ; Subscribe to our Newsletter. Varying body mass index cut-off points to describe overweight prevalence among U.


A follow-up study of forty-two patients for up to 21 years. Recurrence of nonalcoholic steatohepatitis following liver transplantation.

Las tiazolidinedionas, son agentes orales para el tratamiento de pacientes con diabetes mellitus tipo 2 Nutr Rev, 60pp. Am J Cardiol, 70pp. Lack of association between adiponectin levels and atherosclerosis in mice. Adipokines seem insulionrresistencia be the link between obesity and cardiovascular disease. Zhang HL, Jin X. Journal of Clinical Investigation, 72pp. Pflugers Arch – Eur J Physiol ; Longitudinal changes in risk variables of insulin resistance syndrome from childhood to young adulthood in offspring of parents with type 2 diabetes: JAMA,pp.

The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Perivascular adipose tissue modulates vascular function in ineulinorresistencia human internal thoracic artery.

Am J Physiol Cell Physiol ; Interrelationship between serum lipid profile, serum hormones and other components of the metabolic syndrome. Fatty liver hepatitis steathepatitis and obesity: Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. Do high carbohydrate diets prevent the development or attenuate the manifestations or both of syndrome X?


Measurement methods for physical activity and energy expenditure: Handbook of physiology, pp. Insulin sensitivity, lipids and body composition in childhood: Nature,pp. J Intern Med ; Factores predisponentes al desarrollo de diabetes tipo 2 y riesgo cardiovascular en la infancia.

N Engl J Med,pp. J Clin Invest, 97pp. Obes Res, 5pp. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Arterioscler Thromb Vasc Biol, 20pp. Endocrinol Metab, 86pp. Several methods have been devised to assess insulin resistance: Clin Exp Pharmacol Physiol, 25pp. Non-alcoholic steatohepatitis, insulin resistance and metabolic syndrome: Proceedings of the 85 th Annual Meeting [resumen ]. J Intern Med,pp. Unusual patterns of hepatic steatosis caused by the local effect of insulin revealed on chemical shift MR imaging. Consenso SEED O’ para la evaluacion del sobrepeso y la obesidad y el establecimiento de criterios de intervencion terapeutica.

Am J Med,pp.